 | Aclaris Therapeutics, Inc. (NASDAQ:ACRS) to Post Q1 2021 Earnings of ($0.27) Per Share, SVB Leerink Forecasts americanbankingnews.com - March 5 at 8:36 AM |
 | Short Interest in Aclaris Therapeutics, Inc. (NASDAQ:ACRS) Grows By 52.7% americanbankingnews.com - March 5 at 4:14 AM |
 | Aclaris Therapeutics (NASDAQ:ACRS) Shares Up 8% americanbankingnews.com - March 1 at 7:38 PM |
 | William Blair Weighs in on Aclaris Therapeutics, Inc.'s Q1 2022 Earnings (NASDAQ:ACRS) americanbankingnews.com - March 1 at 3:37 AM |
 | Aclaris Therapeutics (NASDAQ:ACRS) Posts Earnings Results, Beats Expectations By $0.01 EPS americanbankingnews.com - February 26 at 1:46 PM |
 | Aclaris Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results and Provides a Corporate Update finance.yahoo.com - February 25 at 8:29 AM |
 | Aclaris Therapeutics (NASDAQ:ACRS) Stock Price Up 8.6% americanbankingnews.com - February 22 at 7:20 PM |
 | Aclaris Therapeutics to Participate in Upcoming Investor Conferences finance.yahoo.com - February 22 at 9:00 AM |
 | Aclaris Therapeutics (NASDAQ:ACRS) Stock Price Down 5.4% americanbankingnews.com - February 18 at 7:28 PM |
 | Aclaris Therapeutics (NASDAQ:ACRS) Reaches New 12-Month High at $25.32 americanbankingnews.com - February 12 at 2:58 PM |
|
 | Aclaris Therapeutics (NASDAQ:ACRS) Trading Up 6.7% americanbankingnews.com - February 10 at 7:34 PM |
 | Aclaris Therapeutics to Participate in the 10th Annual SVB Leerink Global Healthcare Conference finance.yahoo.com - February 10 at 9:06 AM |
 | Gaining Ground After A Tough Couple Of Weeks finance.yahoo.com - January 25 at 7:34 PM |
 | Aclaris aims to raise $96 million through stock offering after shares soar bizjournals.com - January 20 at 9:29 PM |
 | Aclaris Therapeutics' stock jumps on positive data for drug developed by St. Louis-based unit bizjournals.com - January 20 at 4:22 PM |
 | How High Is the Blue Sky for Aclaris Stock? Analyst Weighs In finance.yahoo.com - January 20 at 4:21 PM |
 | Aclaris Announces Pricing of Public Offering of Common Stock finance.yahoo.com - January 20 at 11:21 AM |
 | Aclaris (ACRS) Up on Preliminary Data for MK2 Inhibitor in RA finance.yahoo.com - January 20 at 11:21 AM |
 | Aclaris Explodes 220% On ‘Positive Data’ From Rheumatoid Arthritis Trial finance.yahoo.com - January 20 at 6:20 AM |
 | Is Aclaris Therapeutics a Stock to Buy After Nearly 200% Run-Up and Now This? msn.com - January 19 at 8:20 PM |
 | Aclaris Therapeutics' stock skyrockets 220% on positive data for potential arthritis treatment bizjournals.com - January 19 at 8:20 PM |
 | Aclaris Announces Proposed Public Offering of Common Stock finance.yahoo.com - January 19 at 8:20 PM |
 | Aclaris Triples After Progress in Rheumatoid Arthritis Drug Trial finance.yahoo.com - January 19 at 8:20 PM |
 | Stock Alert: Aclaris Therapeutics Surges 160% nasdaq.com - January 19 at 3:19 PM |
 | Aclaris Therapeutics stock more than triples after 'positive' data on arthritis treatment trial finance.yahoo.com - January 19 at 3:19 PM |
 | Aclaris Therapeutics Announces Positive Preliminary Topline Data from 12-Week Phase 2a Trial of Oral ATI-450 for Moderate to Severe Rheumatoid Arthritis finance.yahoo.com - January 19 at 8:35 AM |
 | Is Aclaris Therapeutics (NASDAQ:ACRS) Weighed On By Its Debt Load? finance.yahoo.com - December 29 at 7:19 AM |
 | Implied Volatility Surging for Aclaris Therapeutics (ACRS) Stock Options finance.yahoo.com - December 23 at 1:56 PM |
 | Is ACRS A Good Stock To Buy Now? finance.yahoo.com - December 16 at 1:16 AM |
 | Aclaris Therapeutics Announces Formation of New Scientific Advisory Board finance.yahoo.com - December 15 at 10:09 AM |
|
 | Aclaris Therapeutics to Participate in the Evercore ISI 3rd Annual HealthCONx Conference finance.yahoo.com - November 16 at 8:51 PM |
 | How Much Does Aclaris Therapeutics' (NASDAQ:ACRS) CEO Make? finance.yahoo.com - November 14 at 8:44 AM |
 | Aclaris Therapeutics (ACRS) Reports Q3 Loss, Tops Revenue Estimates finance.yahoo.com - November 4 at 1:44 PM |
 | Aclaris Therapeutics EPS beats by $0.05, misses on revenue seekingalpha.com - November 4 at 8:43 AM |
 | Aclaris Therapeutics Reports Third Quarter 2020 Financial Results and Provides a Corporate Update finance.yahoo.com - November 4 at 8:43 AM |
 | Dosing underway for Aclaris's ATI-1777 in mid-stage atopic dermatitis study seekingalpha.com - October 20 at 8:38 AM |
 | Aclaris Therapeutics Announces First Patient Dosed in Phase 2a Clinical Trial of ATI-1777, an Investigational Topical “Soft” JAK 1/3 Inhibitor, for the Treatment of Moderate to Severe Atopic Dermatitis finance.yahoo.com - October 20 at 8:38 AM |
 | Aclaris (ACRS) Upgraded to Buy: Here's What You Should Know finance.yahoo.com - August 13 at 1:35 PM |
 | Aclaris Therapeutics EPS beats by $0.07, beats on revenue seekingalpha.com - August 7 at 11:33 AM |
 | Aclaris Therapeutics Reports Second Quarter 2020 Financial Results and Provides R&D and Business Highlights finance.yahoo.com - August 7 at 11:33 AM |
 | Aclaris Therapeutics (ACRS) Reports Q2 Loss, Tops Revenue Estimates finance.yahoo.com - August 7 at 11:33 AM |
 | Will Aclaris Therapeutics (ACRS) Report Negative Q2 Earnings? What You Should Know finance.yahoo.com - August 6 at 2:10 PM |
 | Aclaris Therapeutics Inc www.bloomberg.com - July 30 at 11:55 PM |
 | Stock Alert: Aclaris Therapeutics Up 40% www.nasdaq.com - July 20 at 1:11 PM |
 | Aclaris gains ~8% after filing IND for ATI-1777 in dermatitis seekingalpha.com - July 7 at 10:27 PM |
 | Aclaris Therapeutics Submits Investigational New Drug Application for ATI-1777, a Topical “Soft” JAK1/3 Inhibitor, for the Treatment of Moderate to Severe Atopic Dermatitis finance.yahoo.com - July 7 at 5:26 PM |
 | Two more suburban Philadelphia biopharm firms join battle against Covid-19 www.bizjournals.com - June 19 at 1:29 PM |
 | P/E Ratio Insights for Aclaris Therapeutics www.benzinga.com - June 17 at 1:28 PM |
 | Aclaris Therapeutics Takes the Next Big Step Toward COVID Treatment 247wallst.com - June 17 at 1:28 PM |
 | Aclaris Rips Higher Following FDA Approval Of Coronavirus Study www.benzinga.com - June 17 at 1:28 PM |